Facebook
Twitter
Telegram
Report an ErrorAquestive Therapeutics Cash Flow 2011-2024 | AQST
Annual Cash Flow Aquestive Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-6.38 M | -9.82 M | -33 M | -45.5 M | -60.2 M | -13 M | 5.82 M | - | - | - | - | - | - |
Depreciation & Amortization |
1.34 M | 2.39 M | 2.96 M | 3.44 M | 2.9 M | 3.19 M | 3.75 M | - | - | - | - | - | - |
Accounts Payables |
8.93 M | 9.95 M | 8.31 M | 7.09 M | 12.3 M | 20.4 M | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
6.77 M | 5.78 M | 4.04 M | 2.46 M | 2.86 M | 5.44 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Aquestive Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-10.4 M | - | - | - | 8.82 M | - | -18.2 M | - | -14.5 M | - | -24.9 M | - | -14.1 M | - | -31.9 M | -23.6 M | -13.6 M | - | -49.6 M | -34.8 M | -17.7 M | - | -10.2 M | 1.3 M | 785 K | - | 13.2 M | -2.39 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
207 K | - | 218 K | 250 K | 325 K | - | 557 K | 655 K | 727 K | - | 2.23 M | 728 K | 755 K | - | 2.34 M | 1.68 M | 887 K | - | 2.29 M | 1.54 M | 783 K | - | 733 K | 765 K | 940 K | - | 944 K | 938 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
10.5 M | 8.93 M | 9.99 M | 10.7 M | 12.4 M | 9.95 M | 11.1 M | - | 8.5 M | 8.31 M | 6.22 M | 8.1 M | 6.69 M | 7.09 M | 7.09 M | 7.09 M | 7.09 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 20.4 M | 20.4 M | 20.4 M | 20.4 M | 9.6 M | 9.6 M | 9.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.48 M | 7.45 M | 6.63 M | - | 6.18 M | 6.18 M | 6.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
7.73 M | 6.77 M | 7.08 M | 5.95 M | 6.98 M | 5.78 M | 6.72 M | - | 4.63 M | 4.04 M | 2.86 M | 2.84 M | 2.8 M | 2.46 M | 2.46 M | 2.46 M | 2.46 M | 2.86 M | 2.86 M | 2.86 M | 2.86 M | 5.44 M | 5.44 M | 5.44 M | 5.44 M | 4.01 M | 4.01 M | 4.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency